Mobile

An Open-Label, Multicenter, Multinational Study to Assess the Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-Ventilated Patients with Nosocomial Pneumo...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-005079-17

An Open-Label, Multicenter, Multinational Study to Assess the Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-Ventilated Patients with Nosocomial Pneumonia

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To determine the pharmacokinetic (PK) profile of aerosolized amikacin administered via the PDDS Clinical in patients with nosocomial pneumonia caused by gram-negative organisms - To evaluate the safety and tolerability of aerosolized amikacin administered via PDDS Clinical in patients with nosocomial pneumonia caused by gram-negative organisms

Critère d'inclusion

  • Nosocomial Pneumonia

Liens